Havn Life Scienc Stock Price, News & Analysis
Company Description
Havn Life Scienc (OTC Link: HAVLF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $326.4K.
HAVLF stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of HAVLF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Havn Life Scienc (HAVLF) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $326.4K, HAVLF is classified as a micro-cap stock with approximately 28.6M shares outstanding.
Latest News
Havn Life Scienc has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, clinical trial. View all HAVLF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HAVLF Company Profile & Sector Positioning
Havn Life Scienc (HAVLF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing HAVLF often look at related companies in the same sector, including Amarantus Biosci (AMBS), Wesana Health Holdings Inc (WSNAF), Altamira Therapeutics Ltd (CYTOF), Bioasis Tech (BIOAF), and Respirerx Pharma (RSPI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HAVLF's relative position within its industry.